Library / Laws / 116th Congress / House Bills / H.R. 2113
H.R. 2113
To amend titles XI and XVIII of the Social Security Act to provide for drug manufacturer price transparency, to require certain manufacturers to report on product samples provided to certain health care providers, and for other purposes.
| Print stage | Date | Size | ⠃ |
|---|---|---|---|
| Introduced in House | 2019-04-08 | 24.6K | ⠃⠗⠋ |
| Reported in House | 2020-12-24 | 25.4K | ⠃⠗⠋ |